Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 5 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
AESCO from Lokeren, company number BE0687903313, closed financial year 2025 with a result of € -12,316 after tax. For that financial year AESCO recorded a gross margin of € 26,507 and equity of € 333,455. Compared with financial year 2024, the result moved from € 8,574 to € -12,316. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 333,455
▼ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -12,316
▼ still € 8,574 profit in 2024
Profit after tax over the fiscal year.
Loss, nothing to pay out
Reserves fell to € -1.7 million.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 674
▼ 95% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 1,816
▼ 45% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 122,562 | € 50,075 | € 51,268 | € 26,507 | ▼ 48% |
| Profit after taxes | € 73,734 | € -6,713 | € 8,574 | € -12,316 | ▼ € 20,889 |
| Equity | € 343,910 | € 337,197 | € 345,771 | € 333,455 | ▼ 4% |
| Total debts | € 567,627 | € 240,582 | € 215,850 | € 161,852 | ▼ 25% |
| Retained profit | € -1,706,357 | € -1,713,070 | € -1,704,496 | € -1,716,812 | ▼ € 12,316 |
| Balance sheet total | € 911,537 | € 577,779 | € 561,621 | € 495,307 | ▼ 12% |
Key figures of AESCO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to AESCO?
What happened at AESCO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 12,316 (▼ € 20,889 vs 2024). filed late Source: NBB ↗
- Jacques Deny stepped down as director. NBB
- Bio&Nergy stepped down as director. NBB
- Concorde Invest NV stepped down as director. NBB
- Concorde NV stepped down as director. NBB
- Linea Trovata Bioprojects stepped down as director. NBB
- Socofi NV stepped down as director. NBB
- Didier Steenhout stepped down as director. NBB
In short
From € 73,734 profit in 2022 to € 12,316 loss in 2025.
Best year ever: 2022, with € 73,734 profit.
A new publication or filing at AESCO? We notify you, reason included.
Follow AESCODatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Bio&nergy, LINEA TROVATA BIOPROJECTS, CONCORDE INVEST, CONCORDE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
AESCOThe shares are held by Bio&nergy (44.5%), LINEA TROVATA BIOPROJECTS (40%), CONCORDE INVEST (22.2%) and CONCORDE (22.2%).
Directors
According to the 2025 annual accounts
Jacques Deny
Director
Also active at: TOP-CLASS, CONCORDE, CONCORDE INVEST, TOP-CLASS INVEST, SUN INVEST, SLW
since 2019 · until 2023
since 2017 · until 2023
Director
Also active at: SUN INVEST, JUNIS ENERGIES, SUN INVEST IV, SUN INVEST V, SUN INVEST VI, SUN INVEST III, VELDEMAN ENERGIES
since 2019 · until 2023
Director
Also active at: Building Solar Invest, SUN INVEST, JULIS ENERGIES, VAN MAELE ENERGIES, SUN INVEST IV, SUN INVEST V
since 2019 · until 2023
since 2019 · until 2023
since 2019 · until 2023
Didier Steenhout
Director
since 2019 · until 2023
Matthias Vermeersch
Director
Also active at: KONINKLIJKE ATLETIEKASSOCIATIE GENT, SOCOFI, MAVERCO, RUBIO INTERNATIONAL, EQUINE CARE GROUP, SUN INVEST, BENCIS CAPITAL PARTNERS BELGIUM
since 2019 · until 2023
since 2019 · until 2023
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Mosten 14-14A
9160 Lokeren
Mosten 14A
9160 Lokeren
Active since 20 December 2017
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0687.903.313
- VAT number
- BE 0687.903.313
- Registered office
- Mosten 14-14A, 9160 Lokeren
- Names & denominations
- AESCO
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 20 December 2017
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten
Productie van elektriciteit uit niet-hernieuwbare bronnen